Expertise in
6
conditions

Ravi R. Retnakaran

Mount Sinai Hospital, 
ON, CA 
Expertise in
6
conditions
Mount Sinai Hospital, 
ON, CA 

Overview

Ravi Retnakaran practices practicing medicine in Canada.

Mr. Retnakaran is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Gestational Diabetes, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Metabolic Syndrome.

He is actively involved in clinical research, co-authoring 259 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Mount Sinai Hospital, ON, Canada
Other Locations
60 Murray Street, Toronto, ON, Canada

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
Preserving Beta-cell Function in Type 2 Diabetes With Exenatide and Insulin (PREVAIL)
Enrollment Status: Completed
Publish Date: April 11, 2022
Intervention Type: Drug
Study Drugs: Basal insulin, Exenatide, Bolus insulin
Study Phase: Phase 3
A Randomized Controlled Trial to Evaluate Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes: REmission Studies Evaluating Type 2 DM - Intermittent Insulin Therapy (RESET-IT)
A Randomized Controlled Trial to Evaluate Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes: REmission Studies Evaluating Type 2 DM - Intermittent Insulin Therapy (RESET-IT)
Enrollment Status: Completed
Publish Date: October 27, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

259 Total Publications

Impact of semaglutide withdrawal on cardiometabolic profile and physiology of energy balance: Recovery effects after semaglutide termination - The REST trial study protocol.
Impact of semaglutide withdrawal on cardiometabolic profile and physiology of energy balance: Recovery effects after semaglutide termination - The REST trial study protocol.
Journal: PloS one
Published: June 22, 2026

Frequently Asked Questions about Ravi R. Retnakaran

Is Ravi R. Retnakaran a top-rated expert for Gestational Diabetes?

MediFind is an objective health platform that identifies experts based on real-world data. Ravi R. Retnakaran is classified as an Elite expert for Gestational Diabetes, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ravi R. Retnakaran participate in research or clinical trials?

Yes. Ravi R. Retnakaran has published 259 articles and abstracts on conditions like Gestational Diabetes. You can view a list of Ravi R. Retnakaran's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Retnakaran's expertise for a condition
ConditionClose
View All 17 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile